Viridian Therapeutics, Inc./DE (VRDN) Gross margin
Viridian Therapeutics, Inc./DE (VRDN) gross margin by fiscal year — reported gross profit divided by reported revenue.
26.7%FY2016
| Fiscal year | Value | YoY |
|---|---|---|
| FY2016 | 26.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VRDN financial trends
VRDN RevenueVRDN Net incomeVRDN Net marginVRDN Gross profitVRDN Operating incomeVRDN Operating marginVRDN Operating cash flowVRDN Free cash flowVRDN Capital expendituresVRDN Return on equityVRDN Stock buybacksVRDN Dividends paidVRDN Total assetsVRDN Total liabilitiesVRDN Shareholders’ equityVRDN overview →